← back to search

Shaohua Li

Jilin Agricultural University · CN
Area of research
Hepatology · Surgery
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Cancer Immunotherapy and Biomarkers, and Liver Disease Diagnosis and Treatment.
h-index
33
citations
3,873
works
154
NIH funding
primary concept
Medicine
email

Recent publications

Establishment of a mouse model of allergic asthma sensitized and triggered with PM2.5
International Journal of Environmental Health Research 2025cited by 0position: firstdoi
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study
Journal of Clinical Oncology 2022cited by 163position: firstdoi
The pyroptosis-related gene signature predicts prognosis and indicates immune activity in hepatocellular carcinoma
Molecular Medicine 2022cited by 91position: middledoi
Apatinib versus placebo in patients with locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: Post hoc analyses from the REALITY randomized clinical trial.
Journal of Clinical Oncology 2022cited by 1position: middledoi
Hepatic Arterial Infusion Chemotherapy Combined With PD-1 Inhibitors Plus Lenvatinib Versus PD-1 Inhibitors Plus Lenvatinib for Advanced Hepatocellular Carcinoma
Frontiers in Oncology 2021cited by 123position: middledoi
Apatinib vs Placebo in Patients With Locally Advanced or Metastatic, Radioactive Iodine–Refractory Differentiated Thyroid Cancer
JAMA Oncology 2021cited by 91position: middledoi
Development and Validation of a Model Including Distinct Vascular Patterns to Estimate Survival in Hepatocellular Carcinoma
JAMA Network Open 2021cited by 60position: middledoi
Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma
Journal of Hepatocellular Carcinoma 2021cited by 57position: middledoi
Comparison of the Prognostic Value of Inflammation-Based Scores in Patients with Hepatocellular Carcinoma After Anti-PD-1 Therapy
Journal of Inflammation Research 2021cited by 48position: middledoi
Relationship between PD-L1 expression, CD8+ T-cell infiltration and prognosis in intrahepatic cholangiocarcinoma patients
Cancer Cell International 2021cited by 46position: middledoi
A new horizon in risk stratification of hepatocellular carcinoma by integrating vessels that encapsulate tumor clusters and microvascular invasion
Hepatology International 2021cited by 40position: middledoi
Tumor necrosis as a poor prognostic predictor on postoperative survival of patients with solitary small hepatocellular carcinoma
BMC Cancer 2020cited by 67position: middledoi
MicroRNA-206, IL-4, IL-13, and INF-γ levels in lung tissue and plasma are increased by the stimulation of particulate matter with a diameter of ≤2.5μm, and are associated with the poor prognosis of asthma induced pulmonary arterial hypertension patients
Clinical and Experimental Hypertension 2020cited by 12position: firstdoi
Adjuvant transcatheter arterial chemoembolization after curative resection for hepatocellular carcinoma patients with solitary tumor and microvascular invasion: a randomized clinical trial of efficacy and safety
Cancer Communications 2018cited by 184position: middledoi
Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study
Chinese Journal of Cancer 2017cited by 153position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rong Guo · Tsinghua University11 papers (2017–2022)Lianghe Lu · Sun Yat-sen University6 papers (2020–2022)Wei Wei · Zhujiang Hospital6 papers (2018–2021)Jie Mei · Sun Yat-sen University5 papers (2020–2022)Yihong Ling · Sun Yat-sen University5 papers (2018–2022)Lie Zheng · Sun Yat-sen University4 papers (2018–2022)Ming Shi · Ministry of Education of the People's Republic of China4 papers (2017–2021)Minshan Chen · University of Colorado Denver3 papers (2018–2021)Chong Zhong · Guangzhou University of Chinese Medicine3 papers (2021–2022)Jiahong Wang · Harbin Medical University2 papers (2021–2021)Jun Liang · Chongqing Medical University2 papers (2021–2022)Wenxin Chen · Fujian Medical University2 papers (2021–2022)Rongce Zhao · The University of Texas MD Anderson Cancer Center2 papers (2022–2022)Wen‐Ping Lin · Sun Yat-sen University2 papers (2021–2021)Shanghua Jing · Hebei Medical University2 papers (2021–2022)Yongfa Zhang · Sun Yat-sen University Cancer Center2 papers (2021–2021)Wuzhuang Sun · Hebei Medical University2 papers (2020–2025)QiJiong Li · Sun Yat-sen University2 papers (2017–2021)Xuqi Sun · Zhejiang University2 papers (2021–2021)Weibing Miao · Xiamen University2 papers (2021–2022)